About Mycoplasma Testing
The increasing incidence of mycoplasma contamination, as well as increasing research and development activities, will help to boost global Mycoplasma Testing market in the forecasted period. Mycoplasma testing is mainly used to help determine if Mycoplasma pneumonia is the cause of a respiratory tract infection. Also, It used to help diagnose a systemic infection that is thought to be due to mycoplasma. In the biotechnology sector, they are growing used for drug screening and development, and large-scale manufacturing of biological compounds.
Attributes | Details |
---|
Study Period | 2018-2030 |
Base Year | 2023 |
High Growth Market | Asia Pacific |
Unit | Value (USD Billion) |
CAGR | 12.5% |
Analyst at AMA Research estimates that United States Players will contribute the maximum growth to Global Mycoplasma Testing market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.
Thermo Fisher Scientific Inc. (United States), Charles River Laboratories International, Inc. (United States), Lonza Group Ltd. (Switzerland), Merck KGaA (Germany), Roche Diagnostics (Switzerland), SGS S.A. (Switzerland), American Type Culture Collection (United States), Bionique Testing Laboratories, Inc. (United States), InvivoGen (United States) and PromoCell GmbH (Germany) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are WuXi AppTec (United States), Norgen Biotek Corp. (Canada), Agilent Technologies (United States), Biotools, B & M Labs, S.A (Spain), Eurofins Scientific (Luxembourg), Gibraltar Laboratories (United States), GeneCopoeia, Inc. (United States), GenBio (Canada), Hylabs (Israel), Minerva Biolabs GmbH (Germany), Meridian Bioscience, Inc. (United States), Sartorius AG (Germany), Savyon Diagnostics (Israel) and ScienCell Research Laboratories, Inc. (Canada).
Segmentation Overview
AMA Research has segmented the market of Global Mycoplasma Testing market by Type (Instruments, Kits & Reagents [Elimination Kits & Reagent, Standards & Controls, PCR Assay, Stains, Nucleic Acid Detection, Other] and Services), Application (Cell Line Testing, Virus Testing, End of Production Cells Testing and Others) and Region.
On the basis of geography, the market of Mycoplasma Testing has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). North America region held largest market share in the year 2023. Europe, on the other hand, stood as the second largest market due to the presence of key companies in the region and high technological advancement. If we see Market by Technology, the sub-segment i.e. ELISA (Enzyme-linked Immunosorbent Assay) will boost the Mycoplasma Testing market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by End User, the sub-segment i.e. Academic Research Institutions and Organizations will boost the Mycoplasma Testing market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
Influencing Trend:
High Demand Due to Cell Culture Contamination and Huge R&D Investments in Life Sciences
Market Growth Drivers:
Government Support for Pharma as well as Biotech Industry and Technological Advancement in Mycoplasma Testing
Challenges:
Dearth Of Skilled Workforce
Restraints:
Stringent Government Regulations and Growing Concern Regarding High Degree of Consolidation Acts for New Entrants
Opportunities:
Huge Potential for Pharmaceuticals Outsourcing
Market Leaders and their expansionary development strategies
On 14th March 2019, Lonza Expands Mycoplasma Detection Portfolio with New Luminometer Designed to Accelerate and Simplify Testing. The expansion of the portfolio with the new Lucetta™ 2 Luminometer establishes Lonza as the leading provider of fast, simple and accurate mycoplasma detection solutions,
On 10th July 2018, ATCC, the premier global biological materials resource and standards organization and the leading supplier of authenticated cells and advanced cell models, has announced the availability of its new PCR-based service to detect mycoplasma contamination in cell cultures.
Key Target Audience
Mycoplasma Testing Instrument Manufacturers, Mycoplasma Testing Instrument Vendors, Distributors, and Service Providers, Pharmaceutical and Biotechnology Companies, Academic Research Institutes Related to Mycoplasma Testing and Contract Research Organizations
About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.
Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.
The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.